Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Trial Profile

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2015

At a glance

  • Drugs Naratriptan (Primary)
  • Indications Migraine
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 23 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top